loading
Schlusskurs vom Vortag:
$3.41
Offen:
$3.45
24-Stunden-Volumen:
120.66K
Relative Volume:
3.14
Marktkapitalisierung:
$82.44M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-4.3151
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
+17.54%
1M Leistung:
-45.50%
6M Leistung:
+36.96%
1J Leistung:
+105.88%
1-Tages-Spanne:
Value
$3.10
$3.58
1-Wochen-Bereich:
Value
$2.52
$3.76
52-Wochen-Spanne:
Value
$1.04
$7.25

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Name
Firmenname
Cumberland Pharmaceuticals Inc
Name
Telefon
615-255-0068
Name
Adresse
2525 WEST END AVENUE, NASHVILLE,, TN
Name
Mitarbeiter
91
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
CPIX's Discussions on Twitter

Vergleichen Sie CPIX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
CPIX
Cumberland Pharmaceuticals Inc
3.15 82.44M 37.79M -10.38M -1.00M -0.73
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
22.99 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.18 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.25 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.34 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.01 20.17B 16.54B -1.64B 749.00M -1.45

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2012-11-12 Bestätigt UBS Neutral
2011-02-01 Bestätigt UBS Neutral
2010-12-16 Herabstufung UBS Buy → Neutral
2010-08-17 Herabstufung Jefferies Buy → Hold
2010-08-17 Bestätigt Morgan Joseph Buy
2010-08-17 Bestätigt UBS Buy
2010-05-14 Bestätigt Morgan Joseph Buy
Alle ansehen

Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten

pulisher
Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com

Jun 17, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Has $89,000 Stake in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above Two Hundred Day Moving Average – Here’s Why - Defense World

Jun 12, 2025
pulisher
Jun 06, 2025

Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock - Investing.com

Jun 06, 2025
pulisher
Jun 05, 2025

Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight - GlobeNewswire Inc.

Jun 05, 2025
pulisher
Jun 04, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Investors in Cumberland Pharmaceuticals (NASDAQ:CPIX) have seen splendid returns of 235% over the past year - Yahoo

Jun 02, 2025
pulisher
May 27, 2025

NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS - PR Newswire

May 27, 2025
pulisher
May 27, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

May 27, 2025
pulisher
May 22, 2025

Q&A: Cumberland Pharmaceuticals CEO A.J. Kazimi weighs in on industry challenges, strengths - The Business Journals

May 22, 2025
pulisher
May 21, 2025

Cumberland CEO A.J. Kazimi: Pharmaceutical tariffs would be 'concerning' - The Business Journals

May 21, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Cuts Stock Position in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World

May 17, 2025
pulisher
May 14, 2025

Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025 - The Victoria Advocate

May 14, 2025
pulisher
May 13, 2025

Cumberland, Qureight Collaborate on Lung Disease Treatment Trial - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH - PR Newswire

May 13, 2025
pulisher
May 13, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Held Back By Insufficient Growth Even After Shares Climb 30% - simplywall.st

May 13, 2025
pulisher
May 13, 2025

Cumberland Pharmaceuticals Leverages AI Technology to Transform IPF Treatment Research in Major Clinical Trial - Stock Titan

May 13, 2025
pulisher
May 12, 2025

Cumberland Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 12, 2025
pulisher
May 10, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World

May 10, 2025
pulisher
May 07, 2025

Cumberland Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Cumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 06, 2025

Cumberland: Q1 Earnings Snapshot - MySA

May 06, 2025
pulisher
May 06, 2025

Cumberland Pharmaceuticals Inc Reports Q1 2025 Earnings: EPS at $0.16, Revenue Hits $11.7 Million - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Cumberland Pharmaceuticals sees Q1 2025 revenue jump 38% - Investing.com

May 06, 2025
pulisher
May 02, 2025

Cumberland Pharmaceuticals Inc.Common Stock (NQ: CPIX - FinancialContent

May 02, 2025
pulisher
Apr 30, 2025

Renaissance Technologies LLC Sells 21,000 Shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Cumberland Pharmaceuticals Q1 Earnings Call: Key Updates from Specialty Drug Portfolio Coming May 6 - Stock Titan

Apr 29, 2025
pulisher
Apr 28, 2025

Cumberland Pharmaceuticals Shareholders Approve Key Proposals By Investing.com - Investing.com India

Apr 28, 2025
pulisher
Apr 28, 2025

Cumberland Pharmaceuticals Shareholders Approve Key Proposals - Investing.com

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 18, 2025

Cumberland Pharmaceuticals' (NASDAQ:CPIX) growing losses don't faze investors as the stock swells 18% this past week - simplywall.st

Apr 18, 2025
pulisher
Apr 10, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World

Apr 10, 2025
pulisher
Apr 06, 2025

Cumberland Pharmaceuticals director Caroline Young acquires $383 in common stock - Investing.com Australia

Apr 06, 2025
pulisher
Apr 05, 2025

Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock By Investing.com - Investing.com South Africa

Apr 05, 2025
pulisher
Apr 05, 2025

Cumberland Pharmaceuticals director James Jones buys shares worth $880 By Investing.com - Investing.com South Africa

Apr 05, 2025
pulisher
Apr 04, 2025

Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Cumberland Pharmaceuticals CEO A.J. Kazimi acquires $880 in common stock - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Cumberland Pharmaceuticals director James Jones buys shares worth $880 - Investing.com India

Apr 04, 2025
pulisher
Mar 25, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving Average – What’s Next? - Defense World

Mar 25, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 21, 2025
pulisher
Mar 19, 2025

FIGHT DMD trial results selected for late-breaking presentation at MDA clinical & scientific conference - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Breakthrough DMD Heart Disease Treatment Achieves 5.4% Function Boost While Controls Decline - Stock Titan

Mar 19, 2025
pulisher
Mar 19, 2025

FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference - PR Newswire

Mar 19, 2025

Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$14.64
price down icon 0.54%
$9.32
price down icon 0.21%
$129.11
price down icon 0.22%
$294.49
price down icon 0.25%
drug_manufacturers_specialty_generic RDY
$15.08
price up icon 1.34%
$17.01
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):